Webinar | July 19, 2023

Streamlining Viral Vector Development And Manufacturing For Gene Therapies

As clinical success, innovation, and investment in cell and gene therapy grows, emerging therapies are targeting more chronic conditions and cancers, in addition to rare diseases. This makes viral vector manufacturing—a critical component in gene and cell therapy— in demand.

Join viral vector experts to learn about MilliporeSigma's capabilities and solutions for gene therapy production and virtually tour the GMP manufacturing facility.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online